MPPLM
UTHR icon

Midwest Professional Planners Ltd (MPPL)’s United Therapeutics UTHR Stock Holding History

Midwest Professional Planners Ltd (MPPL)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-646
Closed -$73K – 281
2018
Q2 		$73K Buy
646
+21
+3% +$2.31K 0.07% 127
2018
Q1 		$70K Buy
625
+58
+10% +$7.37K 0.06% 131
2017
Q4 		$84K Buy
+567
New +$72.1K 0.08% 125

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Midwest Professional Planners Ltd (MPPL)'s UTHR Position: Q3 2018 in Review

Midwest Professional Planners Ltd (MPPL) sold out of United Therapeutics (UTHR) in Q3 2018, closing a stake of 646 shares — an estimated $73K sold.

Midwest Professional Planners Ltd (MPPL) first reported a position in UTHR in Q4 2017 and held it in 3 quarters. The position peaked at $84K in Q4 2017. 367 funds tracked by Wall St. Rank hold UTHR as of Q3 2018.

  • Midwest Professional Planners Ltd (MPPL) reported no remaining United Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Midwest Professional Planners Ltd (MPPL) sold 646 United Therapeutics shares in Q3 2018, an estimated $73K.
  • Midwest Professional Planners Ltd (MPPL) first reported a position in United Therapeutics in Q4 2017 and held it in 3 quarters.
  • Midwest Professional Planners Ltd (MPPL)'s United Therapeutics position peaked at $84K in Q4 2017.
  • 367 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2018.

Based on Midwest Professional Planners Ltd (MPPL)'s 13F filing for Q3 2018, filed 13 Nov 2018.